Topics

Alfa Scientific Designs, Inc. Company Profile

07:34 EDT 18th September 2019 | BioPortfolio

Alfa Scientific Designs, Inc. is a leader in the development and manufacture of rapid, immunoassay, point-of-care tests. As a minority, woman-owned, small business, ALFA offers a broad range of services, including contract product development, technology transfer, OEM services, custom assembly, and packaging with private labeling. ALFA has more than 50 FDA 510(k) cleared (for professional/OTC use), CLIA-waived and CE Mark products. ALFA’s innovation in research and development has resulted in more than 27 granted patents and numerous partnerships. To learn more about ALFA’s services, development capabilities and partnership opportunities, visit the company’s website at www.alfascientific.com for more information.


News Articles [638 Associated News Articles listed on BioPortfolio]

Comparison of darbepoetin alfa and epoetin alfa for the treatment of renal anaemia

Darbepoetin alfa (DA-α) manufactured by Hetero Biopharma (Hetero) is the first long-acting erythropoiesis-stimulating agent with extended dosing intervals. This gives it an advantage over epoetin alf...

Alfa Plus by Solio receives FDA clearance

Solio recently announced the release of its innovative Alfa Plus, after receiving FDA clearance. Providing relief from chronic pain in addition to pain from trauma, sports injury and The post Alfa Pl...

FDA OKs Turoctocog Alfa Pegol (Esperoct) for Hemophilia A

Turoctocog alfa pegol is an extended half-life factor VIII molecule for treatment and prophylaxis of bleeding episodes and perioperative management in adults and children with hemophilia A. FDA Appr...

Study Designs for Surgical Interventions in Cerebral Palsy

Certain study designs used in cerebral palsy research may impact the validity of the extracted evidence. Should alternative study designs be considered? Current Orthopaedic Practice

PanGen gains Malaysian approval for epoetin alfa biosimilar

South Korea-based biotechnology company PanGen Biotech (PanGen) announced on 7 February 2019 that Malaysia’s National Pharmaceutical Regulatory Agency has granted sales approval for Erisa, an epoeti...

Catalyst Biosciences Presents Updated Data from Its Phase 2/3 Trial of Subcutaneous Marzeptacog Alfa

Catalyst Biosciences (NASDAQ:CBIO) has announced it has presented updated interim data from its Phase 2/3 trial of subcutaneous prophylactic Factor VIIa (FVIIa) variant marzeptacog alfa (activated) (...

Complex Innovative Trial Designs Pilot Program

As displayed in the Federal Register notice on August 1, 2018, FDA is conducting a Complex Innovative Designs (CID) Pilot Meeting Program to support the goal of facilitating and advancing the use of c...

EU grants orphan drug designation to marzeptacog alfa for hemophilia B

Catalyst Biosciences announced that its hemophilia B treatment, marzeptacog alfa, has been granted orphan drug designation in -More- 

Drugs and Medications [63 Associated Drugs and Medications listed on BioPortfolio]

Ribavirin [richmond pharmaceuticals, inc.]

These highlights do not include all the information needed to use ribavirin tablets safely and effectively. See full prescribing information for ribavirin tablets. Ribavirin Tablets for oral useInitia...

Ribavirin [zydus pharmaceuticals (usa) inc.]

These highlights do not include all the information needed to use RIBAVIRIN TABLETS safely and effectively. See full prescribing information for RIBAVIRIN TABLETS. RIBAVIRIN tablets, for oral useIniti...

Ribasphere ribapak [kadmon pharmaceuticals, llc]

These highlights do not include all the information needed to use RIBASPHERE® (ribavirin, USP) safely and effectively. See full prescribing information for RIBASPHERE® (ribavirin, USP). RIBASPHERE®...

Moderiba [abbvie inc.]

These highlights do not include all the information needed to use Moderiba (ribavirin, USP) safely and effectively. See full prescribing information for Moderiba (ribavirin, USP). Moderiba (ribavirin,...

Alferon [hemispherx biopharma, inc]

NA

PubMed Articles [593 Associated PubMed Articles listed on BioPortfolio]

Thrombomodulin alfa prevents the decrease in platelet aggregation in rat models of disseminated intravascular coagulation.

Disseminated intravascular coagulation (DIC), a deadly complication characterized by uncontrolled hypercoagulation, causes a decrease in the platelet count and impairs platelet aggregation. Thrombomod...

JR-131, a biosimilar of darbepoetin alfa, for the treatment of hemodialysis patients with renal anemia: a randomized, double-blinded, parallel-group phase 3 study.

The aim of this study was to compare the efficacy and safety of intravenous JR-131, a darbepoetin alfa biosimilar, to darbepoetin alfa in hemodialysis patients with renal anemia. In this 24-week, mult...

Randomization Procedures for Changing Criterion Designs.

To strengthen the scientific credibility arguments for single-case intervention studies, randomization design-and-analysis methods have been developed for the multiple-baseline, ABAB, and alternating ...

Andexanet Alfa for Urgent Reversal of Apixaban Before Aortic Surgery Requiring Cardiopulmonary Bypass: A Case Report.

Andexanet alfa is a recombinant factor Xa decoy molecule capable of reversing direct and indirect factor Xa-inhibiting anticoagulants. We present an adult patient on apixaban for nonvalvular atrial fi...

Correction to: Damoctocog Alfa Pegol: A Review in Haemophilia A.

The article Damoctocog Alfa Pegol: A Review in Haemophilia A, written by Julia Paik and Emma D. Deeks, was originally published Online First without open access.

Clinical Trials [1926 Associated Clinical Trials listed on BioPortfolio]

Study Comparing Reduction and Viral Safety of IFN Alfa-2b XL + Ribavirin Versus PEG IFN Alfa-2b + Ribavirin in Patients With Chronic Hepatitis C Genotype 1

The purpose of this study is to confirm if IFN alfa-2b XL has a better antiviral activity and tolerability as compared with current marketed reference, while combined with ribavirin, in a ...

Cost-effectiveness Study of Epoetin Alfa and Darbepoetin Alfa in Adult Patients With Cancer Who Have Anemia

The purpose of this study is to evaluate the cost-effectiveness of epoetin alfa compared with darbepoetin alfa in the treatment of anemia in adults receiving chemotherapy for cancer. Epoe...

PROCRIT Extended Dosing For Maintenance of Hemoglobin in Pre-Dialysis CKD Patients

The purpose of this study is to demonstrate that once every-2-weeks and once every-4-weeks treatment with epoetin alfa, a drug that increases red blood cell production, in patients with an...

Corifollitropin Alfa Combined With Menotropin Versus Follitropin and Lutropin Alfa in Expected Suboptimal Responders

In an opened randomized study of women undergoing in vitro fertilization with expected suboptimal response to controlled ovarian stimulation (Poseidon Group 2b) investigators will examine ...

Epoetin Alfa or Darbepoetin Alfa in Treating Patients With Anemia Caused by Chemotherapy

RATIONALE: Epoetin alfa and darbepoetin alfa may cause the body to make more red blood cells. They are used to treat anemia caused by chemotherapy in patients with cancer. PURPOSE: This r...

Companies [1533 Associated Companies listed on BioPortfolio]

Alfa Scientific Designs, Inc.

Alfa Scientific Designs, Inc. is a leader in the development and manufacture of rapid, immunoassay, point-of-care tests. As a minority, woman-owned, small business, ALFA offers a ...

Assisted Living Federation of America (ALFA)

The Assisted Living Federation of America (ALFA) is the largest national association exclusively dedicated to professionally managed assisted living communities and the seniors an...

Alfa Laval

Alfa Laval is a leading global provider of specialized products and engineered solutions. Our equipment, systems and services are dedicated to helping customers to optimize the performance of their pr...

Assisted Living Federation of America

The Assisted Living Federation of America (ALFA) is the largest national association exclusively dedicated to professionally managed assisted living communities and the seniors and families they serve...

Alfa Wassermann, Inc

Under one name or another, Alfa Wassermann, Inc. has provided high quality products and services to the health care community since 1960. Our parent company, the Alfa Wassermann Group, headquartered i...

More Information about "Alfa Scientific Designs, Inc." on BioPortfolio

We have published hundreds of Alfa Scientific Designs, Inc. news stories on BioPortfolio along with dozens of Alfa Scientific Designs, Inc. Clinical Trials and PubMed Articles about Alfa Scientific Designs, Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Alfa Scientific Designs, Inc. Companies in our database. You can also find out about relevant Alfa Scientific Designs, Inc. Drugs and Medications on this site too.

Quick Search

Relevant Topics

Diagnostics
A diagnostic test is any kind of medical test performed to aid in the diagnosis or detection of disease. For example: to diagnose diseases to measure the progress or recovery from disease to confirm that a person is free from disease Clin...

Drug Approvals
In order to become availible to pateints, drugs need to undergo a number of phases of clinical trials to test their efficacy and safty and to then be authorised by the drug approval organistion in each respective country. This is the FDA in the USA and N...

Alliances, mergers acquisitions and partnerships
BioPortfolio's alliances, mergers acquisitions and partnerships channel provides the latest news and corporate information on the global bio-pharmaceutical industry.


Corporate Database Quicklinks



Searches Linking to this Company Record